Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial

Ulf Holmbäck, Stefan Grudén, Helena Litorp, Daniel Willhems, Sandra Kuusk, Göran Alderborn, Arvid Söderhäll, Anders Forslund

Open source

DOI
10.1002/oby.23557
Published
2022-09-19
Container
Obesity
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/oby.23557,
  title = {Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial},
  author = {Ulf Holmbäck and Stefan Grudén and Helena Litorp and Daniel Willhems and Sandra Kuusk and Göran Alderborn and Arvid Söderhäll and Anders Forslund},
  year = {2022},
  journal = {Obesity},
  doi = {10.1002/oby.23557},
  url = {https://doi.org/10.1002/oby.23557}
}

RIS

TY  - JOUR
TI  - Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial
AU  - Ulf Holmbäck
AU  - Stefan Grudén
AU  - Helena Litorp
AU  - Daniel Willhems
AU  - Sandra Kuusk
AU  - Göran Alderborn
AU  - Arvid Söderhäll
AU  - Anders Forslund
PY  - 2022
JO  - Obesity
DO  - 10.1002/oby.23557
UR  - https://doi.org/10.1002/oby.23557
ER  - 

APA

Holmbäck, U., Grudén, S., Litorp, H., Willhems, D., Kuusk, S., Alderborn, G., Söderhäll, A., & Forslund, A. (2022). Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial. Obesity. https://doi.org/10.1002/oby.23557

Source records